Genetic Variants May Explain High Levels of Antibodies Against Epstein-Barr Virus & 5 Myths About MS episode artwork

EPISODE · Sep 7, 2020 · 11 MIN

Genetic Variants May Explain High Levels of Antibodies Against Epstein-Barr Virus & 5 Myths About MS

from MS News & Perspectives · host MS News Today

Multiple Sclerosis News Today’s columnist, Jenn Powell, discusses how genetic variance may contribute to the increased levels of antibodies against proteins of the Epstein-Barr virus. Plus, Multiple Sclerosis News Today’s columnist, Jessie Ace, reads from her DISabled to Enabled column entitled 5 Myths About MS That Are Actually Not True.=====================================Treatment for Relapsing MS Progression | MAYZENT® (siponimod)Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info.http://ChangesInRMS.com =====================================Are you interested in learning more about multiple sclerosis? If so, please visit:https://multiplesclerosisnewstoday.com/ =====================================To join in on conversations regarding multiple sclerosis, please visit:https://multiplesclerosisnewstoday.com/forums/

Episode metadata supplied by the publisher feed · Published Sep 7, 2020

Embed this episode

NOW PLAYING

Genetic Variants May Explain High Levels of Antibodies Against Epstein-Barr Virus & 5 Myths About MS

0:00 11:54

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of MS News & Perspectives?

This episode is 11 minutes long.

When was this MS News & Perspectives episode published?

This episode was published on September 7, 2020.

Can I download this MS News & Perspectives episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!